创模生物科技(北京)有限公司

CN / En

NEWS

InnoModels Biotechnology: Immune Co-Culture Killing Models

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-04-17 15:06
  • Views:

(Summary description)With the continuous development of biological science and medical technology, human understanding of diseases and treatment modalities are gradually deepening. Among them, immunotherapy, as an emerging therapeutic modality, has shown great potential in fields such as cancer. However, the mechanism of immunotherapy is complex, and how to accurately simulate the immune response process in the body has been a challenge for researchers. For this reason, InnoModels Biotechnology has developed a new 3D immune co-culture killing model, which aims to more realistically simulate the interaction between immune cells and tumor cells in the body, providing a more accurate tool for immunotherapy research.

InnoModels Biotechnology: Immune Co-Culture Killing Models

(Summary description)With the continuous development of biological science and medical technology, human understanding of diseases and treatment modalities are gradually deepening. Among them, immunotherapy, as an emerging therapeutic modality, has shown great potential in fields such as cancer. However, the mechanism of immunotherapy is complex, and how to accurately simulate the immune response process in the body has been a challenge for researchers. For this reason, InnoModels Biotechnology has developed a new 3D immune co-culture killing model, which aims to more realistically simulate the interaction between immune cells and tumor cells in the body, providing a more accurate tool for immunotherapy research.

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-04-17 15:06
  • Views:
Information

With the continuous development of biological science and medical technology, human understanding of diseases and treatment modalities are gradually deepening. Among them, immunotherapy, as an emerging therapeutic modality, has shown great potential in fields such as cancer. However, the mechanism of immunotherapy is complex, and how to accurately simulate the immune response process in the body has been a challenge for researchers. For this reason, InnoModels Biotechnology has developed a new 3D immune co-culture killing model, which aims to more realistically simulate the interaction between immune cells and tumor cells in the body, providing a more accurate tool for immunotherapy research.
1. 3D tissue simulation: restoring the real immune environment
Traditional immune models can only simulate simple cell-cell interactions, but cannot fully restore the complex immune environment in the body. The 3D immune co-culture killing model of InnoModels Biotechnology, however, constructs a more realistic 3D tissue structure through precise cell culture technology, which better simulates the complex interactions between immune cells and tumor cells in vivo. This three-dimensional structure not only provides a closer cell survival environment in vivo, but also simulates the spatial distribution and interaction between cells, making the experimental results more informative.
2、Multi-cell type participation: comprehensive simulation of immune response
Compared with traditional immune models, the 3D immune co-culture killing model of InnoModels Biotechnology is able to introduce a variety of immune cell types at the same time, such as natural killer cells (NK cells), T cells, etc. This involvement of multiple cell types makes it possible to simulate the immune response in a comprehensive way. This involvement of multiple cell types enables the model to simulate more complex immune response processes, and the experimental results are more biologically meaningful. In addition, this visualization also enables researchers to intuitively observe the killing process of immune cells, which helps to gain a deeper understanding of the mechanism of immunotherapy.

 


3、Application Prospects: Helping Immunotherapy Research
The 3D immune co-culture killing model of InnoModels provides strong support for immunotherapy research. Its accurate simulation of the interaction between immune cells and tumor cells in vivo enables researchers to more accurately predict the effects of therapeutic drugs in vivo. This is of great significance for optimizing treatment plans, improving treatment efficiency and reducing side effects. At the same time, the model also helps researchers gain a deeper understanding of the mechanism of immunotherapy, providing new ideas and methods for future immunotherapy.
In conclusion, the 3D immune co-culture killing model of InnoModels has revolutionized immunotherapy research. Its precise simulation of the in vivo immune environment, participation of multiple cell types, and visualization make immunotherapy research more in-depth and comprehensive. With the continuous development and improvement of this technology, it is believed that future immunotherapy will be more accurate and efficient, bringing hope to more patients.

Keyword:

In the vast starry sky of biomedical research, InnoModels Biotechnology (Beijing) Co., Ltd. is like a bright star, illuminating the journey of oncology and tumor immunology drug development with its unique PDX in vivo efficacy model. Today, let's go into InnoModels Biotechnology to learn more about its industry-leading PDX in vivo efficacy model and explore its unlimited potential in drug discovery and development.
In the vast field of cancer research and drug development, InnoModels Biotechnology (Beijing) Co., Ltd. provides powerful support to scientists and doctors with its leading CDX (Cell line-derived xenograft tumor) model platform. The platform not only has diverse tumor cell lines, but also is equipped with a team of experienced experts and advanced experimental technologies, which are dedicated to promoting innovation in biomedical research and clinical treatment.
In the field of life sciences, in vitro killing experimental platform is gradually becoming an important tool for drug development and cell research. Among them, the in vitro killing experimental platform of InnoModels Biotechnology has attracted the attention of many researchers with its unique technical advantages and wide application prospects. In this paper, we will introduce in detail the features and advantages of InnoModels' in vitro killing platform and its applications in scientific research.
In the vast starry sky of biomedical research, InnoModels Biotechnology (Beijing) Co., Ltd. is leading the forefront of tumor and tumor immunotherapy research with its unique in vivo tumor experimental platform, which is like a bright star. The platform not only integrates the most advanced technologies and experimental methods, but also devotes itself to providing a new generation of experimental animal models close to the clinic
In the vast field of life science and drug discovery, in vitro experimental platforms play a crucial role. As a leader in this field, InnoModels Biotechnology (Beijing) Co., Ltd. provides scientists with a highly controlled and precise experimental environment with its in vitro killing platform, which greatly facilitates the screening of new drugs, the study of drug mechanisms, and the development of immunotherapies.
In the broad field of tumor research and new drug development for tumor immunotherapy, InnoModels Biotechnology (Beijing) Co., Ltd. has successfully launched a high mesenchymal tumor transplantation model by virtue of its profound accumulation and technological innovation in the field of model construction, which provides strong support for tumor research and drug development. In this article, we will introduce in detail how InnoModels Biotechnology has made a breakthrough in this field, and explain the importance of high mesenchymal tumor models and their application prospects.
Previous page
1
2
42

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL:15010000264        13810723384

Address:Building 14, Life Valley, Shuangying West Road, Changping District, Beijing

Chuangmo Biotechnology (Beijing) Co., Ltd. Beijing ICP 222*** 98-1 Website Construction: China Enterprise Power Beijing Second Branch Company

北京中因科技有限公司

创模生物科技(北京)有限公司